Maintenance treatment in multiple myeloma: A new era

Preclinical models for small-cell lung cancer

Conducting Oncology Clinical Trials in Africa II: Regulatory Process for Clinical Trials in Africa

Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours plus pembrolizumab

CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer

Phase II data from the KarMMa trial for relapsed/refractory multiple myeloma

Conducting Oncology Clinical Trials in Africa II: Twitter Workshop

Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodgkin lymphoma

Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma

High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer

ASPEN: Results of a phase III randomised trial of zanubrutinib vs ibrutinib for patients with Waldenström macroglobulinemia

Background of the KEYLYNK-007 trial for advanced solid tumours